Back to search

Finland· FI-REL-REL54636

Enteroporc COLI AC

A escherichia vaccine + clostridium vaccine product containing clostridium perfringens type a alpha toxoid + clostridium perfringens type c beta1 toxoid + clostridium perfringens type a beta2 toxoid + f4ab fimbrial adhesin of e. coli + 3 more, registered in Finland by Ceva Santé Animale. The same ATC class is registered in 2 of our 19 countries.

ATC QI09AB08

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEnteroporc COLI ACATCQI09AB08REGISTER NO.FI-REL-REL54636PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Clostridium perfringens type a alpha toxoid + clostridium perfringens type c beta1 toxoid + clostridium perfringens type a beta2 toxoid + f4ab fimbrial adhesin of e. coli + 3 more is registered in 2 of 19 countries.

Countries holding a registration under ATC QI09AB08 (escherichia vaccine + clostridium vaccine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Clostridium perfringens type a alpha toxoid + clostridium perfringens type c beta1 toxoid + clostridium perfringens type a beta2 toxoid + f4ab fimbrial adhesin of e. coli + 3 more · ATC QI09AB08

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Clostridium perfringens Type A alpha toxoid + Clostridium perfringens Type C beta1 toxoid + Clostridium perfringens Type A beta2 toxoid + F4AB Fimbrial adhesin of E. Coli + 3 more
Manufacturer
Ceva Santé Animale
Country
Finland (FI)
ATC code
QI09AB08
ATC class
Escherichia vaccine + Clostridium vaccine
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e67b947d-abc5-4bd6-9640-cb6b9cff0e6c
GET /v1/drugs/e67b947d-abc5-4bd6-9640-cb6b9cff0e6c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "kuiva-aine, kylmäkuivattu, ja suspensio, injektionestettä varten, suspensio",
  "route": "Lihakseen",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Escherichia vaccine + Clostridium vaccine",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/20/262/001-005",
  "fimea_rel_id": "REL54636",
  "authorised_at": "2020-12-09"
}

See everything about clostridium perfringens type a alpha toxoid + clostridium perfringens type c beta1 toxoid + clostridium perfringens type a beta2 toxoid + f4ab fimbrial adhesin of e. coli + 3 more.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.